Peri-operative fluid warming in elective caesarean section

ISRCTN ISRCTN33931714
DOI https://doi.org/10.1186/ISRCTN33931714
Secondary identifying numbers N0060187568
Submission date
28/09/2007
Registration date
28/09/2007
Last edited
11/10/2011
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Pregnancy and Childbirth
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Steve Yentis
Scientific

Magill Dept of Anaesthesia, Intensive Care & Pain Management
Chelsea and Westminster Hospital
369 Fulham Road
London
SW10 9NH
United Kingdom

Phone +44 (0)20 8746 8026
Email s.yentis@imperial.ac.uk

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Scientific title
Study objectivesDoes providing warmed intravenous fluid at elective caesarean section reduce the incidence of hypothermia and improve maternal thermal comfort?
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedPregnancy and Childbirth: Caesarean section
InterventionWarmed intravenous fluid vs no warmed intravenous fluid
Intervention typeOther
Primary outcome measureCore body temperature, incidence and severity of shivering and pain (Visual Analogue Scale), thermal comfort score (visual analogue scale), fetal Apgar scores and umbilical cord blood gas measurements (routinely performed at caesarean section)
Secondary outcome measures1. Shivering
2. Self-reported thermal comfort
Overall study start date25/10/2006
Completion date01/12/2007

Eligibility

Participant type(s)Patient
Age groupAdult
SexFemale
Target number of participants75 to be recruited consecutively
Key inclusion criteriaHealthy women with uncomplicated single pregnancy of > 37 weeks’ gestation due for elective caesarean section
Key exclusion criteria1. Pyrexia
2. Inability to take non-steroidal anti-inflammatory (NSAIDs) medication
3. Pre-eclampsia/eclampsia
4. Drug therapy other than antacids and vitamins/minerals
5. Increased risk of intra-operative haemorrhage (eg placenta praevia or accreta).
Date of first enrolment25/10/2006
Date of final enrolment01/12/2007

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Magill Dept of Anaesthesia, Intensive Care & Pain Management
London
SW10 9NH
United Kingdom

Sponsor information

Record Provided by the NHSTCT Register - 2007 Update - Department of Health
Government

The Department of Health, Richmond House, 79 Whitehall
London
SW1A 2NL
United Kingdom

Phone +44 (0)20 7307 2622
Email dhmail@doh.gsi.org.uk
Website http://www.dh.gov.uk/Home/fs/en

Funders

Funder type

Government

Chelsea and Westminster Healthcare NHS Trust (UK)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/10/2009 Yes No